ASCO Applauds Congress for Funding Cures, Expresses Concerns with Underlying Stagnant NIH Budget

Statement by ASCO President Daniel F. Hayes, MD, FACP, FASCO
For immediate release
December 9, 2016


Rachel Martin

“The continuing resolution under consideration in Congress delivers on an important promise to patients by providing more than $300 million to the National Institutes of Health (NIH) for cancer research under the ‘Beau Biden Cancer Moonshot and NIH Innovation Projects’ recently authorized by the 21st Century Cures Act. With this funding, the continuing resolution will help jumpstart the Cancer Moonshot Initiative to accelerate cancer research and end cancer as we know it. We commend congressional appropriators for acting so quickly to fund this important legislation.

“However, the American Society of Clinical Oncology (ASCO) remains concerned that short-term spending bills jeopardize our progress against cancer. A continuing resolution impedes long-term planning by the NIH and the institutions and scientists the agency supports. In addition, the continuing resolution does not reflect the bipartisan proposals approved by House and Senate appropriators to increase funding for NIH’s existing programs and responsibilities by up to $2 billion. This proposed funding increase is critical to make up for years of stagnant funding and increase the NIH’s purchasing power in order to begin to catch up and keep up. ASCO urges Congress to work together to pass a full Fiscal Year 2017 funding bill to give NIH the stability it needs to continue its work.”

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube. Visit for the latest cancer-policy developments and read our cancer policy issue briefs for an overview of key policy issues.